BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 33212113)

  • 1. Hemopressin as a breakthrough for the cannabinoid field.
    Heimann AS; Dale CS; Guimarães FS; Reis RAM; Navon A; Shmuelov MA; Rioli V; Gomes I; Devi LL; Ferro ES
    Neuropharmacology; 2021 Feb; 183():108406. PubMed ID: 33212113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of pepcan-23 as pro-peptide of RVD-hemopressin (pepcan-12) and stability of hemopressins in mice.
    Glasmacher S; Gertsch J
    Adv Biol Regul; 2021 May; 80():100808. PubMed ID: 33799079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVD-hemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice.
    Zhang RS; He Z; Jin WD; Wang R
    Neurobiol Learn Mem; 2016 Oct; 134 Pt B():264-74. PubMed ID: 27481221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the cannabinoid receptors by hemopressin peptides.
    Bomar MG; Galande AK
    Life Sci; 2013 Mar; 92(8-9):520-4. PubMed ID: 22884803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling molecules targeting cannabinoid receptors: Hemopressin and related peptides.
    Wei F; Zhao L; Jing Y
    Neuropeptides; 2020 Feb; 79():101998. PubMed ID: 31831183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NFKF is a synthetic fragment derived from rat hemopressin that protects mice from neurodegeneration.
    Heimann AS; Giardini AC; Sant'Anna MB; Dos Santos NB; Gewehr MCF; Munhoz CD; Castro LM; Picolo G; Remer RA; Ferro ES
    Neurosci Lett; 2020 Mar; 721():134765. PubMed ID: 32004656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice.
    Pan JX; Wang ZL; Li N; Han ZL; Li XH; Tang HH; Wang P; Zheng T; Fang Q; Wang R
    Neurosci Lett; 2014 Aug; 578():187-91. PubMed ID: 25010019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemopressin Peptides as Modulators of the Endocannabinoid System and their Potential Applications as Therapeutic Tools.
    Macedonio G; Stefanucci A; Maccallini C; Mirzaie S; Novellino E; Mollica A
    Protein Pept Lett; 2016; 23(12):1045-1051. PubMed ID: 27748182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (m)RVD-hemopressin (α) and (m)VD-hemopressin (α) improve the memory-impairing effect of scopolamine in novel object and object location recognition tasks in mice.
    Zhang R; Lao K; Lu B; Guo H; Cheng J; Chen P; Gou X
    Peptides; 2021 Feb; 136():170442. PubMed ID: 33171279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemopressin is an inverse agonist of CB1 cannabinoid receptors.
    Heimann AS; Gomes I; Dale CS; Pagano RL; Gupta A; de Souza LL; Luchessi AD; Castro LM; Giorgi R; Rioli V; Ferro ES; Devi LA
    Proc Natl Acad Sci U S A; 2007 Dec; 104(51):20588-93. PubMed ID: 18077343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further Characterization of Hemopressin Peptide Fragments in the Opioid and Cannabinoid Systems.
    Szlavicz E; Perera PS; Tomboly C; Helyes Z; Zador F; Benyhe S; Borsodi A; Bojnik E
    Anesth Analg; 2015 Dec; 121(6):1488-94. PubMed ID: 26465932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorexigenic effects induced by RVD-hemopressin(α) administration.
    Ferrante C; Recinella L; Leone S; Chiavaroli A; Di Nisio C; Martinotti S; Mollica A; Macedonio G; Stefanucci A; Dvorácskó S; Tömböly C; De Petrocellis L; Vacca M; Brunetti L; Orlando G
    Pharmacol Rep; 2017 Dec; 69(6):1402-1407. PubMed ID: 29145068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
    Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
    J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emotional disorders induced by Hemopressin and RVD-hemopressin(α) administration in rats.
    Leone S; Recinella L; Chiavaroli A; Martinotti S; Ferrante C; Mollica A; Macedonio G; Stefanucci A; Dvorácskó S; Tömböly C; De Petrocellis L; Vacca M; Brunetti L; Orlando G
    Pharmacol Rep; 2017 Dec; 69(6):1247-1253. PubMed ID: 29128806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel endogenous peptide agonists of cannabinoid receptors.
    Gomes I; Grushko JS; Golebiewska U; Hoogendoorn S; Gupta A; Heimann AS; Ferro ES; Scarlata S; Fricker LD; Devi LA
    FASEB J; 2009 Sep; 23(9):3020-9. PubMed ID: 19380512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors.
    Bauer M; Chicca A; Tamborrini M; Eisen D; Lerner R; Lutz B; Poetz O; Pluschke G; Gertsch J
    J Biol Chem; 2012 Oct; 287(44):36944-67. PubMed ID: 22952224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage.
    Petrucci V; Chicca A; Glasmacher S; Paloczi J; Cao Z; Pacher P; Gertsch J
    Sci Rep; 2017 Aug; 7(1):9560. PubMed ID: 28842619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of rat VD-hemopressin(α), an α-hemoglobin-derived peptide exhibiting cannabinoid agonist-like effects in mice.
    Zheng T; Zhang T; Zhang R; Wang ZL; Han ZL; Li N; Li XH; Zhang MN; Xu B; Yang XL; Fang Q; Wang R
    Neuropeptides; 2017 Jun; 63():83-90. PubMed ID: 28010996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of RVD-hemopressin (α) on feeding and body weight after standard or cafeteria diet in rats.
    Leone S; Ferrante C; Recinella L; Chiavaroli A; Mollica A; Tömböly C; Stefanucci A; Dimmito MP; Dvorácskó S; Verratti V; De Petrocellis L; Orlando G; Brunetti L
    Neuropeptides; 2018 Dec; 72():38-46. PubMed ID: 30396596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central functional response to the novel peptide cannabinoid, hemopressin.
    Dodd GT; Worth AA; Hodkinson DJ; Srivastava RK; Lutz B; Williams SR; Luckman SM
    Neuropharmacology; 2013 Aug; 71():27-36. PubMed ID: 23542442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.